News

  • BReIN - Brightlands e-Infrastructure for Neurohealth

    Twenty million euros for fighting Alzheimer’s using big data

    13-05-2019

    The Province of Limburg, Maastricht UMC+ and Maastricht University (UM) are jointly investing €20 million in a new research institute, called BReIN (Brightlands e-Infrastructure for Neurohealth). The spiritual father of BReIN is Maastricht professor of Environmental Health, Jos Kleinjans.

  • Brightlands Maastricht Health Campus opens base in life science hotspot California

    01-05-2019

    Brightlands Maastricht Health Campus opened a base on the West Coast of the US on Monday 29 April, at the University of California’s business accelerator in Irvine.

  • Tackling tinnitus with behavioural therapy

    25-02-2019

    In the new European treatment guidelines for tinnitus, a therapy developed at Maastricht University (UM) has been designated as the only recommended treatment. It is a form of cognitive behavioural therapy that is currently offered solely by health care centres in Hoensbroek and Eindhoven.

  • Blastocyst-like structures generated solely from stem cells

    Funding for follow-up research into the development of embryos

    20-02-2019

    With a donation of almost 2.7 million euros from the foundation Stichting De Weijerhorst to Maastricht UMC+, new research is being funded into the still virtually unknown core processes between stem cells and other cells that take place in the embryo and in the interactions with the uterus. The research programme is led by the MERLN institute of Maastricht University.

  • UM article top downloaded journal articles

    24-01-2019

    An article of Mayke van Dort PhD at Maastricht University, in 2018 in the series orthopedic magazines in Springer has the most number of downloads, namely more than 43.000.

  • The influence of endocrine disruptors on the male and female thyroid gland

    16-01-2019

    The new European collaborative project SCREENED, coordinated by Maastricht University, aims to develop three-dimensional (3D) cellbased in vitro tests to better characterize the effects of endocrine disruptors on thyroid gland function.

Subscribe to News